On the contrary, YTHDF2 was reported to function as a tumor suppressor in other studies, YTHDF2 inhibited the proliferation and growth of HCC cells via promoting the degradation of epidermal growth factor receptor (EGFR) mRNA, which is the upstream of the ERK/MAPK pathway (68). This evidence concerns the gene EGFR and neoplasm.